The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage
Background and Aim: Every year, traumatic brain injuries lead to more than one million admissions to emergency rooms and more than 50,000 deaths, and millions of disabilities worldwide, among all ages and genders. This study aimed to examine the effects of selenium added to oral nutritional therapy...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Guilan University of Medical Sciences
2022-11-01
|
| Series: | Iranian Journal of Neurosurgery |
| Subjects: | |
| Online Access: | https://irjns.org/article-1-302-en.pdf |
| _version_ | 1811220718641217536 |
|---|---|
| author | Seyedeh Zahra Faritous Zohre Hashemi Mohammadreza Hajiesmaeili Zohreh Morshedizad Hooman Bakhshandeh Soha Mehrabimahani |
| author_facet | Seyedeh Zahra Faritous Zohre Hashemi Mohammadreza Hajiesmaeili Zohreh Morshedizad Hooman Bakhshandeh Soha Mehrabimahani |
| author_sort | Seyedeh Zahra Faritous |
| collection | DOAJ |
| description | Background and Aim: Every year, traumatic brain injuries lead to more than one million admissions to emergency rooms and more than 50,000 deaths, and millions of disabilities worldwide, among all ages and genders. This study aimed to examine the effects of selenium added to oral nutritional therapy on the mortality rate and length of hospital stay in patients with subarachnoid hemorrhage admitted to the intensive care unit (ICU) for six months.
Methods and Materials/Patients: This clinical trial included 100 patients admitted to the ICU of Loghman Hakim Hospital, Tehran, Iran. These patients were then randomly assigned to intervention or control groups. Standard oral solutions were administered to both groups according to recommended guidelines. Along with the standard nutritional intake, the participants in the intervention group were given 1000 μg of selenium (Selenase-Biosyn, Germany) on the first day of feeding, dissolved in 100 mL of normal saline for 30 minutes, followed by 500μg of selenium daily for 10 days. We screened patients for GCS, and APACHE-II scores, as well as cortisol levels on days 1 and 10.
Results: The APACHE-II mean score on the 10th day was significantly different between the two groups, and this was also true before the intervention. In terms of mortality rates, there was no significant difference between the control group and the intervention group. Neither the control group nor the intervention group spent significantly more time in ICU.
Conclusion: The effects of selenium on other variables were unclear, although mortality rates did not differ significantly between the two groups. Considering the confounding variables through regression analysis, the APACHE-II variable was negatively impacted by selenium, but taking into account the significant effect of age, a definitive conclusion cannot be made. |
| first_indexed | 2024-04-12T07:46:21Z |
| format | Article |
| id | doaj.art-3c368e1a21a4426ebaca58452ed26575 |
| institution | Directory Open Access Journal |
| issn | 2423-6497 2423-6829 |
| language | English |
| last_indexed | 2024-04-12T07:46:21Z |
| publishDate | 2022-11-01 |
| publisher | Guilan University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Neurosurgery |
| spelling | doaj.art-3c368e1a21a4426ebaca58452ed265752022-12-22T03:41:41ZengGuilan University of Medical SciencesIranian Journal of Neurosurgery2423-64972423-68292022-11-0180The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid HemorrhageSeyedeh Zahra FaritousZohre HashemiMohammadreza HajiesmaeiliZohreh MorshedizadHooman BakhshandehSoha Mehrabimahani Background and Aim: Every year, traumatic brain injuries lead to more than one million admissions to emergency rooms and more than 50,000 deaths, and millions of disabilities worldwide, among all ages and genders. This study aimed to examine the effects of selenium added to oral nutritional therapy on the mortality rate and length of hospital stay in patients with subarachnoid hemorrhage admitted to the intensive care unit (ICU) for six months. Methods and Materials/Patients: This clinical trial included 100 patients admitted to the ICU of Loghman Hakim Hospital, Tehran, Iran. These patients were then randomly assigned to intervention or control groups. Standard oral solutions were administered to both groups according to recommended guidelines. Along with the standard nutritional intake, the participants in the intervention group were given 1000 μg of selenium (Selenase-Biosyn, Germany) on the first day of feeding, dissolved in 100 mL of normal saline for 30 minutes, followed by 500μg of selenium daily for 10 days. We screened patients for GCS, and APACHE-II scores, as well as cortisol levels on days 1 and 10. Results: The APACHE-II mean score on the 10th day was significantly different between the two groups, and this was also true before the intervention. In terms of mortality rates, there was no significant difference between the control group and the intervention group. Neither the control group nor the intervention group spent significantly more time in ICU. Conclusion: The effects of selenium on other variables were unclear, although mortality rates did not differ significantly between the two groups. Considering the confounding variables through regression analysis, the APACHE-II variable was negatively impacted by selenium, but taking into account the significant effect of age, a definitive conclusion cannot be made.https://irjns.org/article-1-302-en.pdftraumatic brain injuryseleniumsubarachnoid hemorrhageapache iimortality rate |
| spellingShingle | Seyedeh Zahra Faritous Zohre Hashemi Mohammadreza Hajiesmaeili Zohreh Morshedizad Hooman Bakhshandeh Soha Mehrabimahani The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage Iranian Journal of Neurosurgery traumatic brain injury selenium subarachnoid hemorrhage apache ii mortality rate |
| title | The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage |
| title_full | The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage |
| title_fullStr | The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage |
| title_full_unstemmed | The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage |
| title_short | The Effectiveness of Selenium in Oral Nutritional Therapy for Patients With Subarachnoid Hemorrhage |
| title_sort | effectiveness of selenium in oral nutritional therapy for patients with subarachnoid hemorrhage |
| topic | traumatic brain injury selenium subarachnoid hemorrhage apache ii mortality rate |
| url | https://irjns.org/article-1-302-en.pdf |
| work_keys_str_mv | AT seyedehzahrafaritous theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT zohrehashemi theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT mohammadrezahajiesmaeili theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT zohrehmorshedizad theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT hoomanbakhshandeh theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT sohamehrabimahani theeffectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT seyedehzahrafaritous effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT zohrehashemi effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT mohammadrezahajiesmaeili effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT zohrehmorshedizad effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT hoomanbakhshandeh effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage AT sohamehrabimahani effectivenessofseleniuminoralnutritionaltherapyforpatientswithsubarachnoidhemorrhage |